← All candidates
40 insider filings on record.
40 filings on record.
ACADACADIA PHARMACEUTICALS INC
NasdaqGS · Healthcare · $4.83B
$27.63
-2.76% · Sep 15
40 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 12 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$4.83B
Float
128.4M
74% public
Short % float
Pro
Price / profit
12.6
Price / future profit
31.5
Price / sales
4.2
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
35 more transactions on Pro →Context
Wall St
$32.30 avg target
+16.9% vs today · 20 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26$0.02 act−$0.06
Q4 '25$0.14 act−$0.01
Q3 '25$0.42 act+$0.27
Q2 '25$0.16 act+$0.02
Coverage
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett SyndromeZacks · 06-29Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength?Zacks · 06-29The Surprising Reversal That Drove Acadia Pharma Closer To A BreakoutInvestor's Business Daily · 06-26Why Acadia Pharmaceuticals Stock Is Soaring TodayMotley Fool · 06-26
The file stays open
40 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice